Contacts, documents and full notice history are available with a subscription.
Combined Synopsis/Solicitation Expired 2 notices 3 documents

Pharmaceutical Products for CDER Research Studies - IDIQ 75F40126Q132721

Solicitation 75F40126Q132721 Copied Notice ID c407fc550cb74360a58f50c37dab2d61 Copied HEALTH AND HUMAN SERVICES, DEPARTMENT OF — FDA OFFICE OF ACQ GRANT SVCS
SAM.gov
Posted
May 04, 2026
Deadline
May 15, 2026
Set-aside
None
NAICS
325412
PSC
6505

Summary

AI-generated · May 02, 2026

Supply pharmaceutical products for CDER research studies under an Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract. Full requirements, scope, and evaluation criteria are described in the attached combined synopsis/solicitation.

See attached combined synopsis/solicitation.

From Combined Synopsis/Solicitation posted on May 01, 2026

5/4/2026: See attached amendment 1 which updates the SBCX link for the subcontracting plan. See attached combined synopsis/solicitation.

From Combined Synopsis/Solicitation posted on May 04, 2026

Notice history

2
  1. Combined Synopsis/Solicitation Posted May 01, 2026 View
  2. Combined Synopsis/Solicitation LATEST Posted May 04, 2026
    • Description: Description was updated

Details

Solicitation number 75F40126Q132721
Notice ID c407fc550cb74360a58f50c37dab2d61
Notice type Combined Synopsis/Solicitation
Product / Service (PSC) 6505
NAICS 325412
Place of performance USA
Archive date May 30, 2026

Award Information

Not yet awarded

Contacts

primary
Nick Sartain

Email

Phone

Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF
FOOD AND DRUG ADMINISTRATION
FDA OFFICE OF ACQ GRANT SVCS

Place of Performance


USA

Dates

Posted May 04, 2026 3 months ago
Last Updated Aug 06, 2026 1 day ago
Due May 15, 2026 2 months ago